| |
| |
|
| Insider
Information: |
Lamb Peter |
| Relationship: |
EVP, Scientific Strate... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
410,958 |
|
|
Indirect Shares
|
17,105 |
|
|
| Direct
Value |
$8,913,679 |
|
|
|
Indirect Value
|
$371,007 |
|
|
| Total
Shares |
428,063 |
|
|
| Total
Value |
$9,284,686 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
EVP, Scientific Strate... |
2022-12-15 |
410,958 |
2022-12-15 |
17,105 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EXEL |
Exelixis Inc |
EVP, Discovery Research & CSO |
• – – |
2015-10-12 |
4 |
S |
$5.84 |
$1,753,312 |
D/D |
(300,276) |
36,473 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Discovery Research & CSO |
• – – |
2015-10-12 |
4 |
OE |
$5.63 |
$1,690,554 |
D/D |
300,276 |
336,749 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2020-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
213,879 |
347,457 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2019-06-17 |
4 |
AS |
$20.49 |
$2,410,307 |
D/D |
(117,404) |
117,197 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2019-06-17 |
4 |
OE |
$1.70 |
$538,259 |
D/D |
100,000 |
217,197 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2019-06-18 |
4 |
AS |
$20.67 |
$2,067,000 |
D/D |
(100,000) |
117,197 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2019-06-18 |
4 |
OE |
$1.70 |
$263,711 |
D/D |
100,000 |
217,197 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
80,663 |
363,787 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2016-11-09 |
4 |
OE |
$5.04 |
$362,000 |
D/D |
70,000 |
143,600 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2016-11-09 |
4 |
AS |
$13.15 |
$920,500 |
D/D |
(70,000) |
73,600 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2016-12-01 |
4 |
OE |
$4.42 |
$368,800 |
D/D |
70,000 |
143,600 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2016-12-01 |
4 |
AS |
$16.66 |
$1,166,200 |
D/D |
(70,000) |
73,600 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2017-01-03 |
4 |
AS |
$14.63 |
$1,025,636 |
D/D |
(70,000) |
73,600 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2017-01-03 |
4 |
OE |
$4.42 |
$401,800 |
D/D |
70,000 |
143,600 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2017-02-01 |
4 |
OE |
$5.96 |
$484,300 |
D/D |
70,000 |
143,600 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2017-02-01 |
4 |
AS |
$18.65 |
$1,305,500 |
D/D |
(70,000) |
73,600 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2020-12-18 |
4 |
OE |
$1.70 |
$110,500 |
D/D |
65,000 |
348,124 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2020-12-18 |
4 |
AS |
$20.01 |
$1,300,650 |
D/D |
(65,000) |
283,124 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-01-04 |
4 |
AS |
$20.32 |
$1,320,800 |
D/D |
(65,000) |
283,124 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-01-04 |
4 |
OE |
$1.70 |
$110,500 |
D/D |
65,000 |
348,124 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-02-01 |
4 |
OE |
$1.70 |
$110,500 |
D/D |
65,000 |
348,124 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-02-01 |
4 |
AS |
$22.08 |
$1,435,200 |
D/D |
(65,000) |
283,124 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-03-01 |
4 |
AS |
$22.11 |
$1,437,150 |
D/D |
(65,000) |
340,072 |
0 |
% |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-03-01 |
4 |
OE |
$1.70 |
$110,500 |
D/D |
65,000 |
405,072 |
0 |
- |
|
| EXEL |
Exelixis Inc |
EVP, Scientific Strategy & CSO |
• – – |
2021-11-15 |
4 |
D |
$18.10 |
$1,125,150 |
D/D |
(62,163) |
349,077 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
